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ABSTRACT
The cell-cycle inhibitor p21
CDKN1A has been sug-
gested to directly participate in DNA repair, thanks
to the interaction with PCNA. Yet, its role has
remained unclear. Among proteins interacting with
both p21 and PCNA, the histone acetyltransferase
(HAT) p300 has been shown to participate in DNA
repair. Here we report evidence indicating that p21
protein localizes and interacts with both p300 and
PCNA at UV-induced DNA damage sites. The
interaction between p300 and PCNA is regulated
in vivo by p21. Indeed, loss of p21, or its inability to
bind PCNA, results in a prolonged binding to
chromatin and an increased association of p300
with PCNA, in UV-irradiated cells. Concomitantly,
HAT activity of p300 is reduced after DNA damage.
In vitro experiments show that inhibition of p300
HAT activity induced by PCNA is relieved by p21,
which disrupts the association between recombi-
nant p300 and PCNA. These results indicate that p21
is required during DNA repair to regulate p300 HAT
activity by disrupting its interaction with PCNA.
INTRODUCTION
The cyclin-dependent kinase (CDK) inhibitor p21
CDKN1A
plays multiple roles not only as a cell-cycle regulator, but
also as a regulator of transcription and apoptosis (1,2).
In addition, p21 interacts with proliferating cell nuclear
antigen (PCNA), and inhibits DNA synthesis by displa-
cing DNA polymerases, as well as other proteins involved
in DNA replication, from PCNA (3–6). Due to this
behavior, p21 has also been considered as a potential
inhibitor of DNA repair (7,8). However, previous
works suggested that p21 might be required for
DNA repair (9,10), particularly for nucleotide excision
repair (NER). Recently, several ﬁndings have supported
such hypothesis: p21 does not interfere with PCNA
recruitment to DNA repair sites (11,12), nor with
PCNA-dependent NER in vitro (13). In addition,
p21-null human ﬁbroblasts are more sensitive to
UV-induced DNA damage, and show defects in NER
(14). p21 protein is immediately recruited to DNA damage
sites, together with repair factors, such as DNA poly-
merase d, XPG and CAF-1 (12). This event does not occur
in ﬁbroblasts from patients aﬀected by xeroderma
pigmentosum (XP) belonging to complementation group
A (XP-A), thus indicating a NER-related process (12).
Other ﬁndings support an additional role for p21 in
base excision repair (BER), since p21 has been shown to
interact with poly(ADP-ribose) polymerase 1 (PARP-1),
thereby regulating PCNA (15). Lastly, p21 may regulate
translesion DNA synthesis, an error-prone DNA repair
process, to keep the mutation load to low levels (16). All
these lines of evidence indicate that p21 may play an active
role in DNA repair, whose signiﬁcance still requires
further elucidation.
Among proteins known to interact with p21, the
transcriptional co-activator p300 deserves a particular
interest (17), given that this protein has been shown to
interact with PCNA, and to participate in DNA repair
(18). In particular, p300 might play an important role in
the DNA repair of the non-transcribed regions of the
genome, a NER sub-pathway known as global genome
repair (GG-NER) (19). In fact, the histone acetyltransfer-
ase (HAT) activity of p300 has been suggested to provide
chromatin accessibility to the GG-NER machinery,
depending on p53 expression (20). However, the role of
p300 in DNA repair is still unclear and further compli-
cated by the evidence that PCNA has an inhibitory eﬀect
on the p300 HAT activity (21).
Here, we have analyzed whether p21 may have a role in
NER by regulating p300 activity through modulation of
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with both p300 and PCNA at DNA damage sites, and that
p21 may physically interact with p300 in vitro. In addition,
by using human ﬁbroblasts deﬁcient in p21 expression
(22), and through ectopic expression of p21 and p300,
we show that p21 and PCNA may bind independently
to p300, but their mutual interaction regulates binding to
p300, and that persistent binding of p300 to PCNA
inhibits p300 HAT activity during NER. Finally, by
in vitro binding and enzymatic assays, we provide evidence
of a role for p21 in dissociating the interaction of p300
with PCNA, thereby restoring p300 HAT activity.
MATERIALS AND METHODS
Plasmids, proteins andantibodies
p21
wt was cloned in pEGFP-N1 as previously described
(6). RFP-PCNA and Flag-p300 plasmids were kindly
provided by M.C. Cardoso (M. Delbruck Center for
Molecular Medicine, Berlin, Germany) and by P.L. Puri
(Telethon Institute, Rome, Italy), respectively. p21
wt-HA
and p21
PCNA–-HA (mutated in PCNA binding domain)
expression plasmids were previously described (6). Human
PCNA protein, GST-fused full-length p21, a p21 mutant
(ASM19) deﬁcient in PCNA binding (23), or a C-terminal
fragment, were expressed in BL21 bacteria and puriﬁed
as described (23,24). Histidine (6)-tagged human p21
(p21-His, cloned in pET-28 vector, Novagen), was puriﬁed
by HisTrapTM Kit (Amersham). Flag-p300 fusion protein
was purchased from Active Motif (USA).
Rabbit polyclonal anti-p21 (C-19 and N-20), and anti-
p300 (N-15) antibodies were from Santa Cruz. Mouse
monoclonal antibodies to p21
waf1 (CP74 and DCS-60
clones) and to XPG (clone 8H7) were from NeoMarkers.
Mouse monoclonal antibodies to actin (AC40), FLAG
(M2), HA (H7) epitopes and polyclonal anti-GST anti-
body, were from Sigma. Rabbit polyclonal antibodies to
acetyl-histone H3 (K9–K14) and to histone H3, were from
Cell Signaling and Upstate. Mouse monoclonal antibodies
to PCNA (PC10), and to CPDs (TDM-2) were from
DakoCytomation and MBL, respectively. Rabbit anti-
GFP polyclonal antibody was from Molecular Probes.
Cellcultures and UV irradiation
LF1 human lung embryonic ﬁbroblasts and h-TERT-
immortalized human p21
+/+ and p21
/ ﬁbroblasts (gift
from J. Sedivy, Brown University, Providence, RI), were
grown in MEM, or in HAM-F10 medium (Gibco BRL),
respectively, supplemented with 15% foetal bovine serum
(FBS) (22). HEK 293 and HeLa S3 were grown in DMEM
medium supplemented with 10% FBS. Cell transfection
was performed with Eﬀectene (Qiagen), or by calcium
phosphate method.
To follow UV-induced histone H3 acetylation, cells
were pre-treated for 1h with 2mM hydroxyurea, as
described (20).
The siRNA transfections were performed in LF1 cells
using Interferin reagent (Polyplus) and p21-siRNA or
GFP-siRNA (as a control) pools (Dharmacon), for 48h at
the ﬁnal concentration of 10nM.
Cells were either subjected to global (10J/m
2), or local
UV-irradiation (20J/m
2) with a UV-C lamp (254nm),
as described (12).
Cell fractionation, co-immunoprecipitation and
Western blot analysis
Whole cell extracts were prepared in lysis buﬀer contain-
ing 50mM Tris–HCl (pH 7.4), 150mM NaCl, 0.5%
Nonidet NP-40, 1mM EDTA, 1mM phenylmethylsulfo-
nyl ﬂuoride (PMSF), 0.2mM Na3VO4 and a mixture of
protease and phosphatase inhibitor cocktails (Sigma). To
obtain the chromatin-bound fraction, cells were lysed in
hypotonic buﬀer (10mM Tris–HCl, pH 7.4, 2.5mM
MgCl2, 0.5% Nonidet NP-40) containing 1mM PMSF,
0.2mM Na3VO4 and protease and phosphatase inhibitor
cocktails. Lysed cells were washed in hypotonic buﬀer and
chromatin-bound proteins were released with DNase I,
as described (25). Whole or fractionated cell extracts
were incubated with antibodies pre-bound to protein
A-sepharose CLB4 (Amersham), or protein G-magnetic
beads (Dynal, Invitrogen), for 3h at 48C under constant
agitation, washed and eluted from beads by SDS-
denaturing buﬀer, as described (12). The immunoprecipi-
tated proteins were resolved on NuPage 4–12% gradient
gels (Invitrogen), transferred to nitrocellulose membranes,
probed with speciﬁc antibodies and revealed using
enhanced chemiluminescence (Amersham).
Immunofluorescence and confocalmicroscopy analysis
Cells were seeded on coverslips, transfected and locally
irradiated as described earlier and lysed in situ with hypo-
tonic lysis buﬀer before ﬁxation to analyze chromatin-
bound proteins, as described (25). Immunoﬂuorescence
staining with primary antibodies was followed by appro-
priate Alexa 488 or 594-conjugated secondary antibodies
(Molecular Probes). Confocal microscopy analysis, image
capture and processing was performed with a Leica TCS
SP2 confocal microscope, as previously described (12).
Pull-down and competitive bindingassays
Equimolar concentrations (1mM each) of full-length
(GST-p21), GST-p21 (ASM19) mutant that does not
bind PCNA (23), a C-terminal peptide (GST-p21C), or
GST alone were pre-incubated with 250ng of recombinant
Flag-p300 protein for 1h at 48C in 50mM Tris–HCl buﬀer
(pH 8.0), containing 2.5mM MgCl2, 75mM KCl, 10%
glycerol, 1mM dithiothreitol (DTT) and 0.2mM PMSF.
Fifty microliters of GSH-agarose beads were added and
further incubated for 1h under agitation, washed and
eluted by SDS-denaturing buﬀer, as described (24).
For competitive binding assay, 250ng of recombinant
Flag-p300 were pre-incubated with 500ng PCNA, or
with 800ng GST-p21 in 100ml of HAT buﬀer (50mM
Tris–HCl, pH 8.0, 10% glycerol, 1mM DTT, 0.1mM
EDTA, 0.1mM PMSF, 10mM sodium butyrate,
0.5mM acetylCoA) for 30min at 48C. Increasing concen-
trations (molar excess 2.5,1 0 ,2 0 ) of GST-p21, or
PCNA (1.5–10), were added, and further incubated for
30min before addition of 50ml of anti-Flag antibody pre-
bound to protein G-magnetic beads. Samples were kept
1714 Nucleic Acids Research, 2008, Vol. 36, No. 5under agitation for 2h, then washed and eluted by SDS-
denaturing buﬀer.
HAT assay
HAT assay (26) was performed with puriﬁed recombinant
Flag-p300 protein (100ng). Reaction was performed at
308Ci n5 0 ml of HAT buﬀer containing 1mg each of
puriﬁed histones H3 and H4, and 1mCi of
3H-acetyl-
Coenzyme A (Amersham Biosciences; speciﬁc activity 159
GBq/mmol). Recombinant PCNA, p21-His or GST-p21
fusion proteins were added to the reaction, as required.
To follow acetylation kinetics, 200ml reaction volumes
were used, and aliquots of 50ml were taken at 5, 10, 15,
20min and spotted onto GF-C glass ﬁber ﬁlters
(Whatman). Incorporated radioactivity was precipitated
and counted with a Beckman LS 6000 liquid scintillation
instrument. Data were expressed as mean values of counts,
subtracted from background values and normalized to
HAT activity measured in samples containing only p300
and substrates. Statistical analysis was performed with the
Student’s t-test.
RESULTS
p21 localizes and interactswith p300atDNA damage sites
To study the role of p21 during DNA repair, we initially
investigated the possibility that p21 protein could localize
with p300 at DNA damage sites. For this purpose, the
localization of p300 in relation to the main lesion induced
by UV, i.e. cyclobutane pyrimidine dimers (CPDs), was
ﬁrst determined after local UV-irradiation, by immuno-
ﬂuorescence and confocal microscopy analysis. Figure 1A
shows that, although p300 was distributed throughout the
whole nucleus, it partially co-localized with CPDs (merged
yellow spots), as further veriﬁed by analysis of pixel
intensity proﬁles of the two ﬂuorescence signals
(Figure S1a). Co-localization speciﬁcity was checked by
using an antibody against ribonucleoproteins, which did
not co-localize with CPDs (Figure S1b). Then, we
expressed p21 fused to GFP (p21-GFP) in HeLa cells
and performed local UV-irradiation experiments to
evaluate chromatin-binding of p21-GFP and p300 at
DNA damage sites. Figure 1B shows that p300 protein
was again spread throughout the whole nucleus, but p21-
GFP was recruited to sites of DNA damage, spatially
close to endogenous p300. To investigate whether p300
was present close to DNA damage sites where PCNA is
also recruited (12), PCNA fused to Red Fluorescent
Protein (RFP-PCNA) and p300 fused to FLAG epitope
(Flag-p300) were co-expressed in HeLa cells. Similarly to
the endogenous protein, Flag-p300 was distributed
throughout the whole nucleus, but showed also an
accumulation at irradiated spots, where clearly
co-localized with RFP-PCNA, as indicated by the yellow
spots in the merged image (Figure 1C). To assess
whether co-localization was accompanied by physical
interaction between p21 and p300, HeLa cells expressing
p21-GFP (or empty vector pEGFP) were UV-irradiated
and then cells extracts were immunoprecipitated with
anti-GFP antibody. As seen in Figure 2A, p21-GFP,
but not pEGFP, interacts speciﬁcally with p300 and
PCNA, both before and after UV irradiation. The
presence of XPG in the immunoprecipitates conﬁrmed
the previously observed co-localization of XPG and p21-
GFP at UV-irradiated sites (12).
To further characterize the interaction between p21
and p300 in DNA repair process, immunoprecipitation of
endogenous p21 was performed in human ﬁbroblasts,
after isolation of the soluble and the chromatin-bound
fractions. As shown in Figure 2B, anti-p21 antibodies
could immunoprecipitate PCNA, from the soluble frac-
tion of both non-irradiated and UV-irradiated cells.
No signiﬁcant levels of PCNA were immunoprecipitated
from the chromatin-bound fraction of non-irradiated
cells, due to the absence of p21. Interestingly, in the
immunoprecipitates from both fractions of UV-damaged
cells, signiﬁcant levels of p300 and XPG were
detected together with p21 and PCNA. To provide
evidence of a direct physical interaction between p21
and p300, recombinant GST-tagged p21
wt was compared
with a mutant form (p21
ASM19) that does not bind PCNA
(23), or with a C-terminal fragment of p21, in a pull-down
assay with recombinant p300. Both GST-p21
wt and
GST-p21
ASM19 mutant protein, but not the GST-
p21C-terminal fragment, nor GST alone, were able to
physically interact with recombinant p300 (Figure 2C).
Figure 1. p300 co-localizes with p21at sites of DNA damage and DNA
repair. (A) Immunoﬂuorescence confocal microscopy analysis of
chromatin-bound p300 (green ﬂuorescence) at sites of CPDs (red
ﬂuorescence). LF1 ﬁbroblasts grown on coverslips were lysed in situ
and ﬁxed 30min after local UV-irradiation, as described in ‘Materials
and Methods’ section. Scale bar, 10mm. (B) Confocal microscopy
analysis of chromatin-bound p300 immunoﬂuorescence (red) and p21-
GFP autoﬂuorescence (green) detected in HeLa cells at sites of
local UV-irradiation. Transfected cells were UV-irradiated and ﬁxed
as described in ‘Materials and Methods’ section. Scale bar, 10mm.
(C) Confocal microscopy analysis of chromatin-bound Flag-p300
(green immunoﬂuorescence), and RFP-PCNA autoﬂuorescence (red),
detected in HeLa cells after local UV-irradiation. Transfected cells were
UV-irradiated and ﬁxed as described in ‘Materials and Methods’
section. Scale bar, 10mm.
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p300, in addition to DNA repair factors, and that this
binding is not dependent on the C-terminal region
required for interaction with PCNA (1,3).
Interaction of p21 withPCNA regulates mutual
association with p300
In order to understand whether p21 aﬀects the interaction
between p300 and PCNA, cell extracts obtained from
hTERT-immortalized human p21-null (p21
/), and
parental (p21
+/+) ﬁbroblasts were used for immunopre-
cipitation of endogenous p300 with anti-p300 antibody.
As previously reported for primary p21-null ﬁbroblasts
(14), immortalized p21
/ ﬁbroblasts exhibited a higher
sensitivity to UVC-induced DNA damage, and showed
deﬁciency in NER (supplementary Figure S2A and B).
Figure 3A shows that in p21
+/+ ﬁbroblasts, the
interaction between p300 and PCNA occurred to a
higher extent after UV-irradiation, as compared with
untreated control samples. In contrast, the interaction was
already detectable in non-irradiated control samples of
p21
/ ﬁbroblasts, and it was higher in UV-irradiated
samples. To clarify this aspect, a HA-tagged wild-type p21
protein (p21
wt), or a mutant form (p21
PCNA–) unable to
interact with PCNA (27), were expressed in HeLa cells.
After immunoprecipitation with anti-HA antibody
(Figure 3B), it was found that PCNA interacted with
p21
wt-HA both before and after UV-irradiation, while
p300 was present in the immunoprecipitate obtained from
UV-treated cells, being almost undetectable in non-
irradiated control samples. In the samples transfected
with the mutant p21 construct (p21
PCNA–-HA), no
signiﬁcant interaction with PCNA was detectable, as
expected, while p300 protein was present in the immuno-
precipitates from both irradiated and non-irradiated
Figure 2. p21 interacts and physically associates with p300 in vivo and in vitro.( A) Immunoprecipitation (Ip) with anti-GFP antibody on extracts
from HeLa cells expressing pEGFP, or p21-GFP, before and 30min after UV-C irradiation, as described in ‘Materials and Methods’ section. Input
load: 1/30 of cell extracts. (B) Immunoprecipitation (Ip) with anti-p21 antibodies of soluble (S) and chromatin-bound (C-b) fractions from control
and 30min after UV-irradiation (10J/m
2) of LF1 ﬁbroblasts. Immunoprecipitation with irrelevant antibody (Ig) is shown together with bands of
immunoglobulin heavy chains (Ig hc) of anti-p21 antibodies. Input load: 1/30 and 1/15 of soluble or chromatin-bound fraction,
respectively. (C) Direct association between recombinant p300 and p21. Equimolar concentrations (1mM) of full-length GST-p21 (GST-p21
wt), a
p21 mutant that does not bind PCNA (GST-p21
ASM19), a p21C-terminal peptide (GST-p21C) or GST alone were pre-incubated with recombinant
Flag-p300 protein (250ng), and then pulled-down with GSH-agarose beads, as described in ‘Materials and Methods’ section. The lower portion of
the gel shown was stained with Coomassie, while the upper part was analysed by Western blot (WB) with anti-Flag antibody. M: molecular weight
markers (kDa).
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cipitation was performed with an antibody to p300
protein. Remarkably, the amount of PCNA interacting
with p300 in the samples expressing the p21
PCNA–-HA
protein was signiﬁcantly higher than those expressing
p21
wt-HA. Similarly, the p21 mutant was immunopreci-
pitated with p300 to a higher extent than the p21
wt
protein.
To further characterize this interaction, HA-tagged
p21
wt and mutant proteins were co-expressed with Flag-
tagged p300 in HEK 293 cells. Figure 3C shows that after
immunoprecipitation with anti-Flag antibody, PCNA was
associated with exogenous p300 in cells expressing Flag-
p300 alone, or in combination with mutant p21
PCNA–-HA
protein, but not in samples co-expressing Flag-p300 and
p21
wt-HA. As observed above in HeLa cells, association
of p300 with mutant p21
PCNA–-HA occurred to higher
levels than with p21
wt-HA. These results indicate that, as
well as in vitro, p21 and PCNA may independently bind to
p300 in vivo. However, interaction of p21 with PCNA
regulates mutual association with p300.
Lossof p21 inducesaccumulation andpersistent binding
ofp300 toPCNA inconcomitance withreduction inHAT
activity
To understand whether the expression of p21 could
inﬂuence the recruitment of p300 and PCNA to DNA
damage sites, this process was investigated in p21
+/+
and p21
/ ﬁbroblasts. Time course analysis of
chromatin-bound proteins (Figure 4A) in p21
+/+ ﬁbro-
blasts showed that PCNA was recruited to chromatin
after UV-irradiation and its levels remained relatively
constant with time. Levels of p300 did not change initially
(as also shown in Figure 1A, B and C), but a decline was
observed at late repair times (11). In contrast, both PCNA
and p300 accumulated with time in the chromatin-bound
fraction of p21
/ cells, as also shown by immunoﬂuore-
scence (Figure S3). In order to conﬁrm by a diﬀerent
approach that prolonged binding to chromatin of p300
and PCNA after DNA damage was related to the
absence of p21, expression of this protein was silenced
by RNA interference (RNAi) in primary LF1 ﬁbroblasts.
Figure 3. p21 modulates the interaction between p300 and PCNA. (A) Immunoprecipitation (Ip) with anti-p300 antibody, or irrelevant IgG (Ig) of
whole cell extracts from p21
+/+ and p21
/ ﬁbroblasts, obtained before or 30min after UV-irradiation, as described in ‘Materials and Methods’
section. Input load: 1/30 of cell extracts. (B) Immunoprecipitation (Ip) with irrelevant antibody (Ig) with anti-HA or with anti-p300 antibodies, of
whole cells extracts from HeLa cells non-transfected (nt) or transfected with plasmid for expression of p21
wt-HA (p21
wt), or p21
PCNA-HA
(p21
PCNA). Input load: 1/30 of cell extracts. (C) Immunoprecipitation (Ip) with anti-Flag antibody of whole cell extracts from 293 cells transfected
(tr.) or not according to the scheme reported: no plasmid (lanes 1,5), Flag-p300 plasmid (lanes 2 and 6), Flag-p300 in combination with p21
wt-HA
(lanes 3 and 7), or with p21
PCNA-HA plasmid (lanes 4 and 8). Input load: 1/30 of cell extracts.
Nucleic Acids Research, 2008, Vol. 36, No. 5 1717Western blot analysis (Figure 4B) showed that at 24h after
UV-irradiation, the levels of chromatin-bound PCNA and
p300 in ﬁbroblasts transfected with siRNA to p21 were
remarkably higher than those detected in cells not exposed
to p21 siRNA, and in cells transfected with control siRNA
(GFP). The persistent binding to chromatin of both p300
and PCNA after UV irradiation suggested that they were
associated. Immunoprecipitation with anti-p300 antibody
(Figure 4C) conﬁrmed that chromatin-bound PCNA and
p300 interacted early after DNA damage (0.5h) in p21
+/+
cells, while their association was undetectable at late
repair time (24h), due to the decrease in p300 levels.
In contrast, the interaction between p300 and PCNA
persisted even 24h after DNA damage, in p21
/
ﬁbroblasts.
It was previously reported that p300 is an accessibility
factor for NER proteins, and that its HAT activity
towards histones H3 and H4 was reduced in
UV-irradiated p53-null human ﬁbroblasts (20). Thus,
we investigated whether this could occur also in
p21-null ﬁbroblasts. Western blot analysis of histone H3
acetylation (K9 and K14 residues) after UV-irradiation of
p21
+/+ and p21
/ human ﬁbroblasts revealed a sig-
niﬁcant reduction in histone H3 acetylation at 3h after
DNA damage (Figure 5A). Cells treated with trichostatin
A (TSA) were added as a control of acetylation.
Densitometric analysis of immunoreactive bands
(Figure 5B) showed that there was a clear reduction in
the ratio acetylated form/total levels of histone H3 (by
about 65% at 3h, P=0.002) in p21
/ ﬁbroblasts, as
compared with p21
+/+ cells. At 24h after UV irradiation,
the decrease was less evident (about 30%), yet still
signiﬁcant (P=0.01).
Given that PCNA inhibits p300 HAT activity (21), and
having shown that in p21
/ cells their interaction persists
after DNA damage, we investigated the eﬀect of the
reduction in p21 levels by RNAi on p300 HAT activity.
Western blot analysis of acetylated forms (K9 and K14)
and total levels of histone H3 showed a signiﬁcant
reduction in acetylated forms (Figure 5C). Densitometric
evaluation of the ratio acetylated form/total level of
histone H3 (Figure 5D), conﬁrmed that reduction in p21
protein levels by RNAi in normal ﬁbroblasts resulted in a
concomitant decrease in HAT activity after UV irradia-
tion, similar to that observed in p21
/ ﬁbroblasts.
p21 dissociates the interaction between p300and PCNA
restoring p300 HAT activity
To provide a functional link between HAT activity and
modulation of p300/PCNA interaction by p21, recombi-
nant Flag-p300 and PCNA were pre-incubated before
addition of increasing amounts of GST-p21, or GST
alone. Immunoprecipitation with anti-Flag antibody
(Figure 6A) showed that PCNA was able to bind directly
to p300 in the absence of GST-p21. Addition of low molar
excess (2.5) amounts of GST-p21 resulted in concomi-
tant binding of GST-p21 and PCNA to p300. In contrast,
higher excess induced the dissociation of PCNA, but also
a reduction in the levels of GST-p21 associated with p300.
In reverse experiments, binding of GST-p21 to p300 was
enhanced by low PCNA concentration (about equimolar
to GST-p21), while a 10-fold excess of PCNA, reduced the
amount of GST-p21 associated to p300 to the levels
observed in the absence of PCNA. The amount of PCNA
still bound to p300 was also reduced at the higher
concentration, again suggesting turn-over of this
interaction.
Given that PCNA inhibits HAT activity of p300 (21),
we performed a HAT assay under conditions of saturat-
ing p21 concentration toward PCNA, and using either a
GST- or histidine-tagged recombinant p21. The results
(Figure 6B) showed that PCNA signiﬁcantly inhibited
p300 HAT activity toward histones H3 and H4, and that
this inhibition was relieved by the addition of p21
wt, but
not by the p21
ASM19 mutant protein. Addition of either
p21
wt or mutant form alone in the absence of PCNA, had
no signiﬁcant eﬀect on p300 HAT activity. Similarly,
addition of GST alone was uneﬀective (not shown).
Neither PCNA, nor p21 appeared to be good substrates
for p300, as compared with histones, in our experimental
conditions (Figure S4). Thus, these results indicate that
p21 dissociates the inhibitory binding of PCNA to p300,
thereby restoring p300 HAT activity.
Figure 4. Loss of p21 enhances chromatin-binding and association
between p300 and PCNA after DNA damage. (A) Western blot
analysis of recruitment of p300, PCNA and p21 proteins in the
chromatin-bound fraction. Human h-TERT–immortalized p21
+/+ and
p21
/ ﬁbroblasts were irradiated with UV-C (10J/m
2), collected at the
indicated time points (h) after UV irradiation, and fractionated as
described in ‘Materials and Methods’ section. Actin was also
determined as a loading control. (B) Western blot analysis of proteins
remaining chromatin-bound 24h after UV-irradiation in LF1 ﬁbro-
blasts not transfected, or transfected with p21-speciﬁc or control (GFP)
siRNA pools. (C) Immunoprecipitation (Ip) with anti-p300 or
irrelevant antibody (Ig) was performed on extracts of chromatin-
bound proteins from p21
+/+ and p21
/ ﬁbroblasts collected 0.5 or
24h after UV irradiation. Input load: 1/15 of nuclear extracts.
1718 Nucleic Acids Research, 2008, Vol. 36, No. 5Figure 5. Loss of p21 results in a reduced HAT activity after UV irradiation. (A) Western blot analysis of acetylated forms (K9-K14) and total
content of histone H3 performed in p21
+/+ (lanes 1–4) and p21
/ (lanes 5–8) cell extracts, before (lanes 1 and 5) and 1h (lanes 2 and 6), 3h (lanes 3
and 7) or 6h (lanes 4 and 8) after UV irradiation. In lane 9, extract from cells treated with trichostatin A (TSA) to enhance H3 acetylated forms, is
shown as positive control of acetylation. (B) Densitometric analysis of the ratio acetylated form (K9–K14)/total levels of histone H3 in p21
+/+
(empty bars) and p21
/ (solid bars) ﬁbroblasts collected 3 or 24h after UV irradiation. Normalized mean valuesSD of three independent
experiments are reported (3h, P=0.002; 24h, P=0.01). (C) Western blot analysis of acetylated form (K9–K14) and of the total levels of histone
H3, and p21. LF1 ﬁbroblasts not transfected, or transfected with p21-speciﬁc or control (GFP) siRNA pools were collected 24h after UV irradiation.
(D) Densitometric analysis of the ratio acetylated form (K9–K14)/total levels of histone H3, in UV-irradiated LF1 ﬁbroblasts not transfected, or
transfected with p21-speciﬁc or control (GFP) siRNA pools. Normalized mean valuesSD of three independent experiments, are reported (P=0.03,
p21-siRNA versus untreated control; P=0.04, p21-siRNA versus GFP-siRNA).
Figure 6. p21 dissociates the binding of PCNA to p300, restoring HAT activity. Competition binding assays: (A) recombinant PCNA (500ng) was
incubated with Flag-p300, in the absence (lane 2), or in the presence of increasing molar excess of GST-p21 protein (2.5,1 0  and 20, lanes 3–5),
or with 10 GST (lane 6). (B) GST-p21 (800ng) was incubated with Flag-p300 in the absence (lane 2), or in the presence of increasing molar excess
of PCNA (1.5,1 0 , lanes 3 and 4). Proteins bound to Flag-p300 were immunoprecipitated (Ip) with anti-Flag antibody and analyzed by Western
blot. Input load (lane 1): 1/2 of Flag-p300, and 1/20 of either PCNA or GST-p21 proteins. (C) HAT assay with recombinant p300 (100ng) in the
absence or in the presence of 0.8mM PCNA, 0.8mM PCNA+8mM p21-His or GST-p21 (p21
wt), 0.8mM PCNA+8mM GST-p21
ASM19 (p21
ASM19)
or p21
wt alone (8mM). The reaction was performed for 10min (i.e. within the linear part of the reaction). Normalized mean values (SD) of
radioactivity counts from three to ﬁve independent experiments are reported (P=0.007, PCNA+p21
wt versus PCNA; P=0.001, p21
wt versus
PCNA).
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The present study suggests that p21 is required to regulate
the HAT activity of p300, which has been indicated to
provide accessibility of NER machinery to DNA damage
sites (20). It was previously shown that p21 could regulate
the transcriptional activity of p300 by modulating the
CRD1 repression domain (28), although no direct binding
was observed within this region of p300 (17). Interestingly,
a low binding level of p21 was observed in the C-terminal
region of p300, which is also involved in the interaction
with PCNA (18). Here, we show that p21 co-localizes at
DNA damage sites and interacts directly with p300, and
that for this activity the full-length protein is probably
required because a C-terminal peptide (capable of inter-
action with PCNA), did not bind to recombinant p300.
In addition, binding of p21 to p300 is not dependent on
interaction with PCNA, given that a p21 mutant unable
to bind PCNA (23) still retained its ability to associate
with p300.
Considering that both p21 and PCNA may indepen-
dently bind to p300, p21 appears to have a role in the
regulation of mutual interaction between p300 and
PCNA. In fact, our in vivo experiments showed that
their association was enhanced, or persisted longer, in the
absence of p21, or in the presence of a mutant protein
unable to bind PCNA. In vitro, it appears that p21 and
PCNA at or near equimolar concentrations, cooperate to
bind p300. In contrast, an excess of one over the other,
induces dissociation from p300. The ability of p21 to
displace PCNA-interacting proteins (PIP) is well known,
at least for those proteins that bind PCNA through the
conserved sequence named PIP box (5). However,
p300 does not seem to have a PIP box (18), and its
interaction with PCNA might be provided by alternative
sequences (29,30).
It has been recently observed that p21 binds to the myc
and cdc25a promoters upon DNA damage, thereby
functioning as a transcriptional inhibitor (31). However,
in that study the presence of PCNA was not investigated,
and no conclusions can be drawn on the eventual
contribution of PCNA to inhibit both transcriptional, as
well as HAT activity of p300 (21).
In this study, we have found that loss of p21 results in a
reduced acetylation of histone H3 in vivo, concomitantly
with a persistent association between p300 and PCNA. In
addition, we have conﬁrmed that PCNA inhibits HAT
activity of p300 in vitro. Remarkably, p21 was able to
relieve the inhibitory eﬀect of PCNA by dissociating the
binding with p300. Thus, our results indicate that p21
regulates the HAT activity of p300 required for NER
(18,20) by disrupting its interaction with PCNA.
Interestingly, it was previously reported that also
p33
ING1b protein was able to dissociate the complex
between p300 and PCNA in a DNA damage-dependent
manner, and that ING1
b overexpression enhanced histone
acetylation (32). However, a direct relation between
p33
ING1b and p300 activity was not investigated in
that study.
It is important to note that the role of p300 in NER
could not be limited to the acetylation of histones. In fact,
it is known that p300 acetylates some proteins participat-
ing in BER, like the endonuclease FEN1 (33), DNA
polymerase b (34), and the DNA glycosylases TDG,
NEIL2, OGG1 and MPG (35–38). In contrast, there is no
substantial information concerning acetylation of NER
factors, and knowledge is limited to the interaction of
p300 with both DDB1 and DDB2 proteins (39,40), XPA
protein (18) and to the evidence that during transcription-
coupled repair, CSB protein recruits p300 onto chromatin,
together with other repair factors (41). In the case of BER,
it is interesting to note that many of the proteins listed
above are known to interact with PCNA (29). Acetylation
may inﬂuence the activity and/or recruitment of such BER
factors to DNA repair sites, suggesting that NER proteins
could be similarly regulated.
Remarkably, p300 appears to contribute to NER by
inducing, in the presence of transcriptional activators
(TA), a transcription-independent chromatin remodeling
process (42). Some of these TAs interact with repair
factors, and are acetylated by p300, thereby modulating
transcription and DNA repair (38,43). Moreover, both
p21 and PCNA may also interact with some of these TAs
(29,44–46), which in turn may also bind to NER factors
(47,48). Based on these lines of evidence and on our
observations, we propose the model illustrated in Figure 7.
Both p21 and PCNA may bind to p300 (and possibly to
TAs) at basal levels. After DNA damage, PCNA is ﬁrst
recruited to sites where p300 is located, thereby sequester-
ing and inhibiting p300 HAT activity, blocking TA
acetylation and promoting the shift from transcription
to DNA repair (35,41,42). Immediately after PCNA, p21
is recruited to the same sites (12) where it may dissociate
p300/PCNA interaction. The released p300 HAT activity
Figure 7. Schematic representation of the hypothetical role of p21 in
global genome repair (GG-NER), through destabilization of the
association of p300 to PCNA. Under normal conditions, both p21
and PCNA may bind to p300 and/or transcriptional activator (TA).
After DNA damage, PCNA is ﬁrst recruited to sites of damaged DNA
where p300 is present, thereby inhibiting HAT activity. Immediately
afterward, p21 is also recruited, until its local concentration is high
enough to bind both PCNA and p300, thereby disrupting their
association. The release of p300 restores its HAT activity, thus
promoting accessibility of PCNA-dependent NER machinery in
surrounding chromatin regions. For simpliﬁcation, NER factors
(e.g. XPG) found in the p21–p300 complex have not been drawn here.
1720 Nucleic Acids Research, 2008, Vol. 36, No. 5may contribute to chromatin remodeling of surrounding
sequences (41), thereby promoting PCNA-dependent
DNA repair of chromatin regions not readily accessible
to NER machinery. In this scenario, another crucial role
for p21 in maintaining genome stability might be played
through the regulation of p300 HAT activity required at
the chromatin level during GG-NER (49).
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